| 000 | 01506 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513041242.0 | ||
| 264 | 0 | _c19950518 | |
| 008 | 199505s 0 0 eng d | ||
| 022 | _a0167-594X | ||
| 024 | 7 |
_a10.1007/BF01058355 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMalkin, M G | |
| 245 | 0 | 0 |
_aSuperiority of PCNU over AZQ in the treatment of primary brain tumors: results of a prospective randomized trial (81-20) by the Brain Tumor Study Group. _h[electronic resource] |
| 260 |
_bJournal of neuro-oncology _c1994 |
||
| 300 |
_a55-65 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAntineoplastic Agents |
| 650 | 0 | 4 |
_aAziridines _xadverse effects |
| 650 | 0 | 4 |
_aBenzoquinones _xadverse effects |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNitrosourea Compounds _xadverse effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aGreen, S B | |
| 700 | 1 | _aByar, D P | |
| 700 | 1 | _aStrike, T A | |
| 700 | 1 | _aBurger, P C | |
| 700 | 1 | _aVogel, F S | |
| 700 | 1 | _aPistenmaa, D A | |
| 700 | 1 | _aMahaley, M S | |
| 700 | 1 | _aRansohoff, J | |
| 700 | 1 | _aShapiro, W R | |
| 773 | 0 |
_tJournal of neuro-oncology _gvol. 22 _gno. 1 _gp. 55-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF01058355 _zAvailable from publisher's website |
| 999 |
_c7713942 _d7713942 |
||